RetinalGenix Technologies Inc.
RTGN · OTCMCIK 1836295fmd_1B64HN7DKCM3NDVWZ5VT03EP7FManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2020 to Jun 30, 2026, 26 periods
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Research and development | 0 | 1 | 1 | 1 | 0 | 0 |
| Total operating expenses | 2 | 2 | 4 | 2 | 4 | 2 |
| Interest expense | – | 0 | 0 | 0 | 0 | 0 |
| Net income | (2) | (2) | (4) | (2) | (4) | (2) |